These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 8980804)

  • 1. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
    Heckert RA; Riva J; Cook S; McMillen J; Schwartz RD
    Avian Dis; 1996; 40(4):770-7. PubMed ID: 8980804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
    Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
    Nagy E; Krell PJ; Dulac GC; Derbyshire JB
    Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
    Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
    Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions.
    Palya V; Kiss I; Tatár-Kis T; Mató T; Felföldi B; Gardin Y
    Avian Dis; 2012 Jun; 56(2):282-7. PubMed ID: 22856183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes.
    Loke CF; Omar AR; Raha AR; Yusoff K
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):259-67. PubMed ID: 15963824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to Newcastle disease virus (NDV) of recombinant fowlpox virus (FPV) expressing a hemagglutinin-neuraminidase of NDV into chickens in the presence of antibody to NDV or FPV.
    Iritani Y; Aoyama S; Takigami S; Hayashi Y; Ogawa R; Yanagida N; Saeki S; Kamogawa K
    Avian Dis; 1991; 35(4):659-61. PubMed ID: 1664717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection in specific pathogen free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination.
    Ganapathy K; Cox WJ; Gough RE; Cargill P; Montiel E; Jones RC
    Avian Pathol; 2007 Aug; 36(4):313-7. PubMed ID: 17620178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safe and effective use of fowlpox virus as a vector for poultry vaccines.
    McMillen JK; Cochran MD; Junker DE; Reddy DN; Valencia DM
    Dev Biol Stand; 1994; 82():137-45. PubMed ID: 7958468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant-attenuated
    Ding K; Shang K; Yu ZH; Yu C; Jia YY; He L; Liao CS; Li J; Zhang CJ; Li YJ; Wu TC; Cheng XC
    J Vet Sci; 2018 Mar; 19(2):232-241. PubMed ID: 29032660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant duck enteritis viruses expressing the Newcastle disease virus (NDV) F gene protects chickens from lethal NDV challenge.
    Ding L; Chen P; Bao X; Li A; Jiang Y; Hu Y; Ge J; Zhao Y; Wang B; Liu J; Chen H
    Vet Microbiol; 2019 May; 232():146-150. PubMed ID: 31030839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity Elicited by a Turkey Herpesvirus-Vectored Newcastle Disease Vaccine in Turkey Against Challenge With a Recent Genotype IV Newcastle Disease Virus Field Strain.
    El Khantour A; Darkaoui S; Tatár-Kis T; Mató T; Essalah-Bennani A; Cazaban C; Palya V
    Avian Dis; 2017 Sep; 61(3):378-386. PubMed ID: 28957008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of viable and inactivated Newcastle disease virus vaccines in turkeys.
    Kelleher CJ; Halvorson DA; Newman JA
    Avian Dis; 1988; 32(2):342-6. PubMed ID: 3401177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus.
    Sun HL; Wang YF; Tong GZ; Zhang PJ; Miao DY; Zhi HD; Wang M; Wang M
    Avian Dis; 2008 Mar; 52(1):111-7. PubMed ID: 18459306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge.
    Taylor J; Christensen L; Gettig R; Goebel J; Bouquet JF; Mickle TR; Paoletti E
    Avian Dis; 1996; 40(1):173-80. PubMed ID: 8713031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.
    Peeters BP; de Leeuw OS; Verstegen I; Koch G; Gielkens AL
    Vaccine; 2001 Feb; 19(13-14):1616-27. PubMed ID: 11166884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.